latest news releases from the newsroom
Northrop Grumman Corp.
Photo Release -- Northrop Grumman Completes Initial MP-RTIP Radar Performance Verification Flights
EL SEGUNDO, Calif., May 28, 2009 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE:NOC) has completed initial testing of the Multi-Platform Radar Technology Insertion Program (MP-RTIP) sensor. All dedicated mode flights have been completed in the Radar System Level Performance Verification (RSLPV) program, verifying system performance of the Synthetic Aperture Radar (SAR) and Ground Moving Target Indicator (GMTI) modes.
KMG Chemicals Schedules Third Quarter News Release and Conference Call for Thursday, June 4th
HOUSTON, May 28, 2009 (GLOBE NEWSWIRE) -- KMG Chemicals, Inc. (Nasdaq:KMGB), a global provider of specialty chemicals in carefully focused markets, today announced that it will issue its financial results for the third quarter ended April 30, 2009 on Thursday, June 4, 2009 before the stock market opens. Neal Butler, President and CEO, and John Sobchak, CFO, will conduct a conference call focusing on the financial results at 10:00 a.m. ET on Thursday, June 4, 2009. Interested parties may participate in the call by dialing 866-861-6730. Please call in 10 minutes before the call is scheduled to begin, and ask for the KMGB call (conference ID # 97209160).
Caris Life Sciences
Caris Diagnostics Expands Personalized Medicine Services to Include BRAF Mutational Analysis for Colon Cancer Patients
IRVING, Texas and PHOENIX, May 28, 2009 (GLOBE NEWSWIRE) -- Caris Diagnostics (Caris Dx), a leading provider of integrated anatomic pathology and oncology testing services, including molecular profiling and hematopathology, announced today that it has expanded its Target GI Colon(sm) tumor testing panel for colorectal cancer (CRC) patients to include BRAF mutation analysis. With the expansion, Target GI Colon(sm) is now one of the most comprehensive colorectal testing panels available, leading to better, more effective therapeutic choices for colon cancer patients.